Skip to main content

Advertisement

Table 2 Relationship between the SUVmax and clinicopathological/IHC findings

From: Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma

  ADC SUVmax   SQC SUVmax  
Factor (n =52) (Mean ± SD) P value (n =32) (Mean ± SD) P value
Age    0.778    0.747
 <70 years 30 6.4 ± 5.1   11 8.4 ± 4.5  
 ≥70 years 22 6.9 ± 5.3   21 8.9 ± 3.4  
Sex    0.230    -
 Male 24 7.6 ± 5.5   32 8.8 ± 3.7  
 Female 28 5.8 ± 4.8   0   
Tumor differentiation    0.008    0.565
 Well 30 4.1 ± 3.3   2 12.0 ± 2.1  
 Moderate 16 8.5 ± 5.4   21 8.3 ± 3.9  
 Poor 6 14.1 ± 2.7   9 9.1 ± 3.6  
Pleural invasion    0.001    0.077
 No 38 5.0 ± 4.0   26 8.2 ± 3.7  
 Yes 14 11.1 ± 5.4   6 11.2 ± 3.2  
Vascular invasion    0.001    0.602
 No 33 4.7 ± 4.0   18 9.1 ± 3.8  
 Yes 19 9.9 ± 5.5   14 8.4 ± 3.7  
Nodal status    0.007    0.075
 Negative 44 5.6 ± 4.6   26 8.1 ± 3.5  
 Positive 8 12.0 ± 4.9   6 11.6 ± 3.7  
Cox-2 expression    <0.001    0.048
 Negative 18 2.8 ± 2.4   19 7.7 ± 3.6  
 Positive 34 8.7 ± 5.1   13 10.3 ± 3.5  
Ki-67 expression    0.001    0.016
 Negative 26 4.3 ± 3.3   15 7.0 ± 4.0  
 Positive 26 9.0 ± 5.7   17 10.3 ± 2.9  
VEGF expression    0.004    0.719
 Negative 17 3.9 ± 4.1   16 9.0 ± 4.3  
 Positive 35 8.0 ± 5.1   16 8.5 ± 3.3  
  1. ADC: adenocarcinoma, Cox-2, cyclooxygenase-2; IHC, immunohistochemical; SQC: squamous cell carcinoma; SUVmax, maximal standardized uptake value; VEGF, vascular endothelial growth factor.